Literature DB >> 8409334

Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis.

C V Paya1, R H Wiesner, P E Hermans, J J Larson-Keller, D M Ilstrup, R A Krom, S Rettke, T F Smith.   

Abstract

Risk factors for cytomegalovirus and severe bacterial infections were studied prospectively by univariate, multivariate and time-dependent Cox model analysis in 79 consecutive liver transplant patients treated with selective bowel decontamination. Cytomegalovirus infection occurred in 39 patients (49%) and was symptomatic in 22 patients. Twenty-six patients (33%) developed at least one of 43 documented severe bacterial infections. In a multivariate analysis of risk factors for all cytomegalovirus infections, the cytomegalovirus seronegative recipient-cytomegalovirus seropositive donor group was the highest risk group (P < 0.001). Using the same analysis for risk factors for symptomatic cytomegalovirus infections, a prolonged prothrombin time (P < 0.005), a diagnosis of acute fulminant hepatitis as the underlying liver disease (P < 0.01) and a cytomegalovirus seronegative patient receiving a liver from a seropositive donor (P < 0.001) were significant. The treatment with OKT3 therapy (P < 0.008) and hepatic artery thrombosis (P < 0.02) were found to be significant risk factors in a time-dependent univariate analysis but were not independent risk factors when multivariate analysis was utilized. Significant risk factors for major bacterial infections (P < 0.03) using univariate analysis included a prolonged anesthesia, anhepatic and surgical times, as well as the transfusion of large amounts of fresh frozen plasma or autologous blood. In a multivariate analysis, only the transfusion of large amounts of fresh frozen plasma (P < 0.04) was a significant independent risk factor. Cytomegalovirus infection was a risk factor for the development of severe bacterial infections (P < 0.03) in a multivariate time-dependent analysis.

Entities:  

Mesh:

Year:  1993        PMID: 8409334     DOI: 10.1016/s0168-8278(05)80245-4

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  16 in total

1.  Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation.

Authors:  Alexander B Benson; James R Burton; Gregory L Austin; Scott W Biggins; Michael A Zimmerman; Igal Kam; Susan Mandell; Christopher C Silliman; Hugo Rosen; Marc Moss
Journal:  Liver Transpl       Date:  2011-02       Impact factor: 5.799

Review 2.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 3.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

4.  Increased serum iron levels and infectious complications after liver transplantation.

Authors:  Jennifer K Chow; Barbara G Werner; Robin Ruthazer; David R Snydman
Journal:  Clin Infect Dis       Date:  2010-08-01       Impact factor: 9.079

5.  Auxiliary partial orthotopic versus standard orthotopic whole liver transplantation for acute liver failure: a reappraisal from a single center by a case-control study.

Authors:  D Azoulay; D Samuel; P Ichai; D Castaing; F Saliba; R Adam; E Savier; M Danaoui; A Smail; V Delvart; V Karam; H Bismuth
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

6.  Human cytomegalovirus inhibits differentiation of monocytes into dendritic cells with the consequence of depressed immunological functions.

Authors:  Sara Gredmark; Cecilia Söderberg-Nauclér
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Histological diagnosis of cytomegalovirus hepatitis in liver allografts.

Authors:  F Colina; N T Jucá; E Moreno; C Ballestín; J Fariña; M Nevado; C Lumbreras; R Gómez-Sanz
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

8.  Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients: a Focus on Prevention.

Authors:  Karen C Tsai; Lara A Danziger-Isakov; David B Banach
Journal:  Curr Infect Dis Rep       Date:  2016-01       Impact factor: 3.725

9.  Pharmacokinetics of ganciclovir in pediatric renal transplant recipients.

Authors:  Daolun Zhang; Anne-Laure Lapeyraque; Michel Popon; Chantal Loirat; Evelyne Jacqz-Aigrain
Journal:  Pediatr Nephrol       Date:  2003-07-23       Impact factor: 3.714

Review 10.  Cytomegalovirus and chronic allograft rejection in liver transplantation.

Authors:  Liang-Hui Gao; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.